NewslettersHuman Immunology NewsImmune Regulation NewsQuoin Pharmaceuticals Enters Exclusive Research Agreement for Scleroderma Treatment with Australian UniversityBy Danielle Corrigan - May 27, 20220292Quoin Pharmaceuticals Ltd. announced it has signed a second, exclusive research agreement with the Queensland University of Technology, Australia.[Quoin Pharmaceuticals, Ltd.]Press Release